1. A systematic review and meta-analysis of the effect of prophylactic tranexamic acid treatment in major benign uterine surgery.
- Author
-
Topsoee, Märta F., Settnes, Annette, Ottesen, Bent, and Bergholt, Thomas
- Subjects
- *
TRANEXAMIC acid , *UTERINE surgery , *MYOMECTOMY , *ANTIFIBRINOLYTIC agents , *META-analysis , *THERAPEUTICS , *SURGICAL blood loss , *BLOOD transfusion , *CESAREAN section , *CLINICAL trials , *GYNECOLOGIC surgery , *SYSTEMATIC reviews , *PREVENTION - Abstract
Background: The value of tranexamic acid (TA) treatment as bleeding prophylaxis in major uterine surgery is unclear.Objectives: To evaluate the antihemorrhagic effect of prophylactic TA treatment in major benign uterine surgery.Search Strategy: PubMed, Embase, Cochrane Library, and Web of Science were searched from 1980 to 2015 without language restriction using search terms related to major uterine surgery combined with TA.Selection Criteria: Randomized controlled trials comparing prophylactic TA with placebo or no intervention in women undergoing elective major benign uterine surgery.Data Collection and Analysis: Basic information and outcomes were collected and meta-analyses performed.Main Results: Sixteen trials were included, with five trials considered to have an overall low risk of bias. In cesarean delivery, TA significantly reduced intraoperative bleeding (mean -136 mL, 95% confidence interval [CI] -189 to -83), blood loss of more than 1000 mL (relative risk 0.38, 95% CI 0.18-0.81), and blood transfusion (relative risk 0.32, 95% CI 0.17-0.59). In abdominal myomectomy, TA also significantly reduced intraoperative bleeding (mean -251 mL, 95% CI -391 to -110).Conclusions: Prophylactic TA treatment significantly reduced operative bleeding in women undergoing elective cesarean delivery or abdominal myomectomy. Additional randomized trials with low risk of bias are needed. [ABSTRACT FROM AUTHOR]- Published
- 2017
- Full Text
- View/download PDF